RETRACTED: Godugu et al. Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780

Kavitha Godugu,Mehdi Rajabi,Shaker A. Mousa
DOI: https://doi.org/10.3390/cancers16101880
2024-05-16
Cancers
Abstract:The journal retracts the article, "Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma" [...]
oncology
What problem does this paper attempt to address?
The paper was initially aimed at studying the anticancer activity of thyroid integrin αvβ3 antagonists mono-triazole and di-triazole tetraiodothyroacetic acid, linked through polyethylene glycols (PEG), in glioblastoma. However, subsequent investigations revealed instances of image fabrication or manipulation in the paper, including image manipulation, reuse, and relabeling. Since the authors were affiliated with Albany College of Pharmacy and Health Sciences, the institution requested the retraction of the paper. Although the authors submitted amendments, they failed to adequately address the issues present in the original images, raising concerns about the validity of the experiments. Ultimately, the Editor-in-Chief of the journal "Cancers" approved the retraction of the paper. The authors disagreed with this retraction decision.